Countdown to
#ANZUP25 ASM

Days
Hours
Minutes
Seconds
ANZUP 2024/25 Annual Report Now Available
Read the Report
#ANZUP25 ASM
20–22 July 2025
Hyatt Regency Sydney
'Listen, Reflect, Connect'
Register Now
Another way to save lives
BCG+MM study offers alternative treatment for bladder cancer patients amid immunotherapy shortage
Read more here
ANZUP at ASCO 2025
ANZUP is proud to showcase the exciting outcomes from ANZUP’s globally significant studies across four oral presentations and four posters at the ASCO 2025 in Chicago - it's been the largest presence ANZUP has ever featured on the main stage.
Find Out More
TheraP ctDNA manuscript published in Nature Medicine
ANZUP's TheraP trial reveals how a simple blood test could transform prostate cancer treatment.
Read more here
Leave a Bequest or Legacy in your Will
Leaving a gift in your Will to ANZUP is a deeply meaningful way to support the advancement of cancer research.
Find Out More
ANZUP Strategy 2025-2028
Click Here to Read
Every meaningful advance in treatment has been the result of a clinical trial
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group mission is to improve treatments and outcomes for people affected by Below the Belt cancers.
Find out more
ANZUP x Sydney Sock Project
That’s right, we have partnered up with the Sydney Sock Project to design and produce a variety of cheeky socks. Say hello to the ‘Banana Sock’ and ‘Bum Sock’.
Grab a Pair
Donate to
improve lives!
Your Gift
Your Details
Your Payment

xx Gift of $xx

Go back
Go back

Or enter your own donation amount

0
Trials
0 +

Sites

0 +

Patients Enrolled

0

Countries

ANZUP Cancer, ANZUP

What we do

ANZUP is the leading cancer cooperative clinical trials group that brings together all of the professional disciplines and groups involved in researching and treating below the belt (penile, bladder, kidney, prostate and testicular) cancers and conduct high quality clinical research.

ANZUP identifies gaps in evidence and areas of clinical need, collaborates with the leading clinicians and researchers in below the belt cancers, and communicate frequently and effectively with the broader community along the way.
Read More
ANZUP Cancer, ANZUP

Join ANZUP

If you are not yet an ANZUP member then join our large multidisciplinary network of urogenital and prostate cancer researchers, clinicians, nurses, psychologists, scientists, allied health and consumer representatives. Membership is free.
If you are a member of the community and would like to learn more about below the belt cancers, then join ‘Friends of ANZUP’.
Read More
ANZUP Cancer, ANZUP

Trials and Research

All of the major milestones in controlling cancer worldwide have come through clinical trials, but we still have a long way to go to help every person affected, at risk or diagnosed with this disease.

We have clinical trials across each cancer type, in various stages of progress: in activation, open to patient recruitment, in follow up and completed trials.
Read More

Telehealth and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations.

Read More

Teleheath and Teletrials

Teletrials builds on the telehealth model and increases access to clinical trials for people with cancer living in rural and remote locations, or in self-isolation due to COVID-19. Teletrials also allows trials recruitment and activity to continue.

Read More

ANZUP Follow

The Australian and New Zealand Urogenital and Prostate cancer trials group aims to develop, foster and promote prostate and other urogenital cancer research

ANZUPtrials
Retweet on Twitter ANZUP Retweeted
binnyj50 Belinda Jago @binnyj50 ·
21 Jul

Great day was had by the @ANZUPtrials Consumer Advisory Panel and guests attending our annual education day #ANZUP25 . Always a special day, meeting face to face instead of zoom. #consumer #engagement #clinicaltrials @Prof_IanD @SamanthaROakes
#BTBcancers

Reply on Twitter 1947088041346269193 Retweet on Twitter 1947088041346269193 1 Like on Twitter 1947088041346269193 6 Twitter 1947088041346269193
Retweet on Twitter ANZUP Retweeted
tiansterzhang Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @tiansterzhang ·
21 Jul

@ChrisSweens1 with comprehensive landscape talk in only 5 mins (!!), highlighting the #DASLHiCAP darolutamide role for high risk #prostatecancer. Pending further follow up. @ANZUPtrials #ANZUP25

Reply on Twitter 1947119489939808593 Retweet on Twitter 1947119489939808593 5 Like on Twitter 1947119489939808593 11 Twitter 1947119489939808593
Load More

Latest News